First Trust NYSE Arca Biotechnology Index Fund
154 hedge funds and large institutions have $622M invested in First Trust NYSE Arca Biotechnology Index Fund in 2018 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 51 increasing their positions, 37 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
154
Holders Change
+24
Holders Change %
+18.46%
% of All Funds
3.53%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.11%
New
36
Increased
51
Reduced
37
Closed
10
Calls
$4.67M
Puts
$2.01M
Net Calls
+$2.66M
Net Calls Change
+$105K
Top Buyers
| 1 |
NA
Navellier & Associates
Reno,
Nevada
|
+$22.7M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$15.6M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$15.3M |
| 4 |
Morgan Stanley
New York
|
+$9.57M |
| 5 |
MIAN
Mariner Independent Advisor Network
Overland Park,
Kansas
|
+$4.62M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$3.26M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.2M |
| 3 |
HFS
HL Financial Services
Louisville,
Kentucky
|
-$1.73M |
| 4 |
HH
Hilltop Holdings
Dallas,
Texas
|
-$1.35M |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$1.28M |
